AEterna Zentaris Inc. is Today's Focus Stock on MicroStockProfit.com
June 29 2010 - 6:50AM
MicroStockProfit.com announces an investment report featuring
AEterna Zentaris Inc. (Nasdaq:AEZS). The report includes financial,
comparative and investment analyses, and recent company news that
you need to know to make an educated investment decision.
Our trade alerts and ideas are provided free to investors.
Simply use your email address to subscribe with
http://www.microstockprofit.com to get the inside track on our next
red-hot alert.
The full report is available at:
http://www.microstockprofit.com/lp/AEZS
AEZS is trading within its Bollinger Bands. This is a normal
condition and suggests that the stock is neither overbought nor
oversold relative to the recent price action.
AEterna Zentaris Inc. (AEZS) is a late-stage drug development
company specializing in oncology and endocrine therapy. The
Company's product pipeline encompasses compounds at all stages of
development, from drug discovery through marketed products. The
priorities in oncology are its phase III program with perifosine in
multiple myeloma and its phase II program in multiple cancers,
including metastatic colon cancer, as well as phase II program with
AEZS-108 in advanced endometrial and advanced ovarian cancer
combined with potential developments in other cancer indications.
In endocrinology, the Company's program is the reactivation of a
phase III trial with AEZS-130 (SolorelTM) as a growth hormone (GH)
stimulation test for the diagnosis of GH deficiency in adults
(AGHD).
Message Board Search for AEZS:
http://www.boardcentral.com/boards/AEZS
In the report, the analyst notes:
"The Company recently announced a collaborative study with
Almac's Diagnostics division for AEZS-108, the Company's
doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted
conjugate compound, which is being investigated in multiple
cancers. The Company said the collaboration is aimed at determining
LHRH receptor expression through the development of a companion
diagnostic tool.
"AEZS last week announced that it has completed its previously
announced registered direct offering of $12.1 million units
comprised of common shares and common share purchase warrants to
certain institutional investors ... According to the Company,
proceeds from the transaction will be used to fund its AEZS-108,
AEZS-112 and AEZS-130 programs and for other general corporate and
working capital purposes."
To read the entire report visit:
http://www.microstockprofit.com/lp/AEZS
See what investors are saying about AEZS at penny stock
forum
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.com
Brian Johnson
1-888-307-2850
info@microstockprofit.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024